A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.

Journal of enzyme inhibition and medicinal chemistry

Volumn 24, Issue 4, 2009, Pages 1040-1044

  Kassa, Jiri ^a   Karasova, Jana ^a   Bajgar, Jiri ^a   Kuca, Kamil ^a   Musilek, Kamil ^a   Kopelikova, Irena ^a  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 CARBOXYPYRIDINIUM) 4 (4 HYDROXYIMINOMETHYLPYRIDINIUM) BUT 2 ENE; 1 (4 HYDROXYIMINOMETHYLPYRIDINIUM) 4 (4 METHYLCARBONYLPYRIDINIUM) BUT 2 ENE; 1-(4-CARBOXYPYRIDINIUM)-4-(4-HYDROXYIMINOMETHYLPYRIDINIUM)-BUT-2-ENE; 1-(4-HYDROXYIMINOMETHYLPYRIDINIUM)-4-(4-METHYLCARBONYLPYRIDINIUM)-BUT-2-ENE; ANTIDOTE; CHOLINESTERASE INHIBITOR; CHOLINESTERASE REACTIVATOR; OBIDOXIME; ORGANOPHOSPHATE; OXIME; PYRIDINIUM DERIVATIVE; TABUN; TRIMEDOXIME;

ANIMAL; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; MALE; MOUSE; RAT; WISTAR RAT;

ANIMALS; ANTIDOTES; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; MALE; MICE; OBIDOXIME CHLORIDE; OXIMES; PHOSPHORIC ACID ESTERS; PYRIDINIUM COMPOUNDS; RATS; RATS, WISTAR; TRIMEDOXIME;

EID: 76249095746     PISSN: None     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360802608419     Document Type: Article

References (0)